Regenicin, Inc. Proceeds from Notes Payable
Regenicin, Inc. reported Proceeds from Notes Payable of $335.68 thousand for the 12-month period ending 2020-09-30, per its 10-K/A filed 2022-03-25.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2022-03-25
- Regenicin, Inc. proceeds from notes payable for the quarter ending 2020-09-30 was $0.00.
- Regenicin, Inc. proceeds from notes payable for the quarter ending 2020-06-30 was $0.00.
- Regenicin, Inc. proceeds from notes payable for fiscal 2020 was $335.68K.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|---|
| 2020-09-30 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-03-25 | $0.00 derived: sum of 2 quarters · filed 2022-03-25 | $335.68K 10-K/A · filed 2022-03-25 | |
| 2020-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-23 | $335.68K 10-Q · filed 2021-08-23 | ||
| 2020-03-31 | $335.68K 10-Q · filed 2021-05-17 |